Epidemiological studies have correlated lower maternal periconceptionallevels of plasma folate and cobalamin with increased risk of delivering offspring presenting congenital malformations such as cleft lip with or without cleft palate (CLIP) or neural tube defects. A number of genetic studies aimed at correlating these biochemical levels or the occurrence of malformations with specific genetic defects or polymorphisms have been successfully performed. The cubilin gene (CUBN) codes for a carrier that plays a crucial role in cobalamin cell internalization. CUBN polymorphisms were previously found to be associated with spina bifida occurrence. In this work, a familybased association study was performed to test CUBN involvement in CLIP. A sample of 391 CLIP triads was investigated with three single nucleotide polymorphisms mapping on the cubilin gene. Association tests indicated no significant association between CLIP and marker alleles or marker haplotypes. No evidence of maternal effect and imprinting were obtained. These data suggest that CUBN is not involved in CLIP onset in the investigated Italian population.
Cleft lip with or without cleft palate (CLIP) as well as neural tube defects (NTD) are considered multifactorial diseases caused by a combination of genetic predisposition and unfavourable environmental factors. Neural crest cells trigger the formation of both neural structures and the face. Migrating neural crest cells settle in five prominences that grow and fuse with each other to develop the face of the embryo between the fourth and the eighth week of gestation. Loss of facial prominence fusion, due to poor proliferation and/or insufficient migration of neural crest cells may cause cleft lip and/or cleft palate. Epidemiological studies have shown that lower levels of serum folate and cobalamin (also named Vitamin B 12 ) are related to an increased risk of developmental abnormalities including CLIP and NTD (I -4). The effect of cobalamin status in patients with CLIP has not been studied as extensively as has in NTD cases.
In mammalian cells, cobalamin is a cofactor for a number of metabolic pathways, including the methylation of homocysteine to methionine, a process that also requires folate (5) . Defects in cobalamin (Cbl) metabolism or low cobalamin dietary intake, result in homocysteine accumulation in plasma. Intracellular cobalamin transport requires the involvement of three cobalamin-binding proteins and specific cell membrane receptors. Cobalamin is only produced by bacteria, thus, it must to be obtained from food, bound to animal proteins. In the stomach, cobalamin is removed from proteins by pepsin and gastric acid, then bound by haptocorrin (HC), that is produced by salivary glands. Gastric parietal cells produce intrinsic factor (IF), a key molecule for cobalamin absorption. In the ileum, HC is degraded by pancreatic enzymes, and Cbl is transferred to the IF. In the terminal ileum, the IF-Cbl complex binds to IF receptors on the enterocytes membrane and undergoes absorption. Subsequently, cobalamin is released into the bloodstream bound to transcobalamin, the major plasma transporter.
The cubilin gene (CUBN) encodes for the IF-Cbl receptor, a 460-KDa transmembrane protein that is important for the intestinal absorption of cobalamin. Crucially, during embryonic development, cubilin mediates IF-Cbl endocytosis at the placental maternalfoetal interface level. Indeed, it is expressed by a number of absorptive epithelial elements, including yolk sac extra embryonic visceral endoderm, ileum and renal proximal convoluted tubule and during the development of the neural tube (6) . Loss of intrinsic factor functions, ultimately, leads to a cobalamin deficiency in humans (7) , although, malabsorption of cobalamin may be related to mutations in genes coding for proteins that playa key role in the internalization processes (8) .
An association between the genetic polymorphisms of key molecules in cobalamin/folate metabolism and inborn malformations has been shown by several authors. The genetic variants C677T and A1298C, mapping on MTHFR gene, have been widely investigated, especially in association with CLIP and NTD (9, 10) . A number of studies have investigated the role of A2756G and A66G polymorphisms, mapping in the methionine syntase (MTR) and methionine syntase reductase (MTRR) genes, respectively, in modifying the risk of cleft lip and palate and neural tube defects (11, 12) . TCN2 gene encodes for transcobalamin 2, a protein involved in the transport of cobalamin within plasma. Transcobalamin 2 facilitates the cellular uptake of cobalamin through receptor-mediated endocytosis of the TCN2-Cbl complex in peripheral tissue. Cobalamin is released into cells and converted to methylcobalamin (MeCb), as it is a methyl group donor for the remethylation of homocysteine to methionine. C776G polymorphism in the TCN2 gene has been found to be associated with CLIP (11) . Finally, in a recent casecontrol study, SNP rs1907362, mapping on the CUBN gene, was found to be associated with spina bifida and able to influence biochemical parameters such as RBC folate and vitamin B12levels (13) .
Epidemiological studies have shown the importance of folic acid and cobalamin supplementation, during the periconceptional period, in relation to a reduction in CLIP and spina bifida occurrence. The analysis of genes involved in folate and cobalamin metabolism could provide insight into a genetic predisposition to CLIP. The aim of the present study, was to investigate a possible association between CUBN gene polymorphisms and the occurrence of CLIP in the Italian population.
MATERIALS AND METHODS

Sample study and markers
A sample study consisting of a 391 Italian case-parent triads was collected for this investigation. While 114 patients had a positive history of CLIP, 277 were considered to have sporadic or non-familial CLIP, since no other relative shared the same malformation. CLIP was the only disorder affecting the probands. Peripheral blood samples were collected after obtaining informed consent. DNA was extracted accordingly to a manual protocol (14) and subsequently typed for three Single Nucleotide Polymorphisms (SNPs) located in the CUBN locus (lOp12.31). The selection of the SNPs was based on literature data and database information. rs1907362, which maps onto CVBN intron 27 was selected because it has recently been found to be associated with folate and cobalamin levels (13) . Two additional SNPs (rsI801231 and rs1801222), were picked up with the aid of the Applied Biosystems SNP Browser Software among nonsynonymous CVBN variations with low inter-marker linkage disequilibrium and minor allele frequency> 0.1. Marker information is summarised in Table 1 .Genotypes were obtained using an ABI7500 Sequence Detection System and TaqMan Chemistry according to Applied Biosystems protocols (Applied Biosystems, Foster City, CA).
Statistical analysis
The distribution of the genotypes among both proband and parent groups was tested for deviations from the Hardy-Weinberg equilibrium using Pearson's X2 test. A family-based allelic association and haplotype analysis was performed with the TDTPHASE program, part of the UNPHASED package, version 2.403 (15) . The program setting for pairwise analysis was featured to perform the standard transmission disequilibrium test (TDT). The haplotype analysis was restricted to phase-certain haplotypes only, in a conditional logistic regression model. This is the same as the ETDT test, which ensures a valid test for either genetic linkage or allelic association (16) . The analysis tested the transmission distortion for all the test haplotypes (global P value), and transmission distortion for each specific haplotype. A rare haplotype frequency threshold of 0.03 was adopted, since likelihood ratio statistics may be sensitive to rare haplotypes.
A log-linear method for the analysis of case-parents triad data, based on maximum likelihood with stratification by parental mating type, was used to test different genetic hypotheses. The log-linear model allows for causal scenarios in which the child's own genotype is directly relevant to risk, as is the mother's, where parental imprinting plays an important role, or the truth is a combination of these factors (17) . The method was implemented using LEM software (18) 
RESULTS
A family-based association approach was adopted to test the involvement of CUBN genetic polymorphisms in CLIP aetiology. The hypothesis of association in the presence of linkage was tested with the standard TDT. No single allele was significantly associated with CLIP; indeed, allele transmission showed no significant departure from the Mendelian expectation (Table II) . A haplotype analysis of the CUBN locus confirmed no association with CLIP (Table II) , although some of two-or three-SNPs haplotypes revealed transmission distortion at nominal levels of significance. Indeed, the haplotype rs1907362(C)-rs1801231(C) resulted overtransmitted to probands (124 transmission vs. 93 untransmission, P = 0.047) and the haplotype rsI801222(C)-rsI907362(C)-rsI801231(T) resulted undertransmitted (5 vs. 18 times, P = 0.007). A permutation test performed to correct significance levels due to multiple comparisons indicated that the adjusted P values were >0.05. In addition to the standard TDT, we implemented a log-linear model for the analysis of the case-parent triads which included parameters for the potential effect of the child's genotype, the maternal genotype, and imprinting in CLIP aetiology. Specific hypotheses about all the above mentioned effects, as well as a combination of them, were tested by comparing the likelihood of suitable nested models with the corresponding likelihood-ratio X2. None of the models were supported at nominal levels of statistic significance.
DISCUSSION
CLIP is one of the most frequent congenital malformations in humans. Its aetiology is multifactorial, due to both environmental and genetic factors. CLIP, as well as neural NTD, are birth defects that may be caused by the alteration of proliferation and/or migration of neural crest cells, that are fundamental for embryonic development of the neural tube and face. Over the last decade, several studies have focused on the importance of folic acid intake, during the periconceptional period, in preventing birth defects. The folate pathway includes a number of cobalamin dependent enzymes. Reduced cell availability for cobalamin or folate, results in the accumulation of homocysteine in plasma. The intracellular transport of cobalamin requires the involvement of three cobalamin-binding proteins and their cell membrane receptors: haptocorrin, intrinsic factor, cubilin, and transcobalamin. Genetic defects negatively influencing one of these elements could impair the cobalamin internalization process.
The aim of the present study was to assess the potential role of the CUBN gene in CLIP aetiology. A family-based association study was performed with a sample of 391 Italian patient-parents triads. Three SNPs were analyzed, including two nonsynonymous variations and an intronic polymorphism that may modulate folate and cobalamin levels (13) . Results indicated that the investigated polymorphisms did not influence the risk of developing CLIP. In addition, a log-linear approach used to test different causal scenarios provided no evidence of maternal effect or imprinting.
The study design was aimed to maximize the chance of obtaining a signal in case CUBN was involved in CLIP onset. Indeed, considering the large sample size, the linkage disequilibrium map of the CUBN locus, and the low intermarker correlation, a large number of genetic polymorphisms should have been tagged by the investigated polymorphisms. This implies that not only did the three tested SNPs did not correlate with a risk of CLIP, but also that it is very likely that CUBN gene is not involved in CLIP onset in the Italian population.
